129 related articles for article (PubMed ID: 10894016)
1. [Diuretics and electrolytes].
Ritz E; Frey FJ
Ther Umsch; 2000 Jun; 57(6):343-4. PubMed ID: 10894016
[No Abstract] [Full Text] [Related]
2. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries.
Singh P; Forman H; Adamson AS; Mostaghimi A; Ogdie AR; Oganisian A; Barbieri JS
J Gen Intern Med; 2019 Feb; 34(2):176-178. PubMed ID: 30324292
[No Abstract] [Full Text] [Related]
3. Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas.
Lee AJ; Bandari J; Macleod LC; Davies BJ; Jacobs BL
J Gen Intern Med; 2019 Feb; 34(2):187-189. PubMed ID: 30402818
[No Abstract] [Full Text] [Related]
4. High Costs and Caution Yield Slow Start for New Heart Drugs.
Kuehn BM
Circulation; 2018 Jan; 137(2):197-199. PubMed ID: 29311350
[No Abstract] [Full Text] [Related]
5. The practitioner, the patient, the resident, and the pharmaceutical "gift".
Harlass FE; Uharriet P; Sakakini J
Mil Med; 1995 Sep; 160(9):A10. PubMed ID: 7478023
[No Abstract] [Full Text] [Related]
6. Margaret McCartney: Second use patents--why do we have to prescribe branded Lyrica for pain?
McCartney M
BMJ; 2015 May; 350():h2734. PubMed ID: 25995105
[No Abstract] [Full Text] [Related]
7. The good, the bad, and the ugly of free drug samples.
Katz KA; Reid EE; Chren MM
JAMA Dermatol; 2014 Nov; 150(11):1238. PubMed ID: 25188905
[No Abstract] [Full Text] [Related]
8. Rising prescription drug costs: whose responsibility?
Hill SR; Henry DD; Smith AJ
Med J Aust; 1997 Jul; 167(1):6-7. PubMed ID: 9236749
[No Abstract] [Full Text] [Related]
9. The good, the bad, and the ugly of free drug samples.
Poligone B
JAMA Dermatol; 2014 Nov; 150(11):1237-8. PubMed ID: 25188835
[No Abstract] [Full Text] [Related]
10. Drug samples in dermatology: out of the closet, into the dustbin.
Katz KA; Reid EE; Chren MM
JAMA Dermatol; 2014 May; 150(5):483-5. PubMed ID: 24740350
[No Abstract] [Full Text] [Related]
11. Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing.
Hadland SE; Cerdá M; Li Y; Krieger MS; Marshall BDL
JAMA Intern Med; 2018 Jun; 178(6):861-863. PubMed ID: 29799955
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
Mitchell AP; Winn AN; Dusetzina SB
JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
[TBL] [Abstract][Full Text] [Related]
13. Tracing the US opioid crisis to its roots.
DeWeerdt S
Nature; 2019 Sep; 573(7773):S10-S12. PubMed ID: 31511672
[No Abstract] [Full Text] [Related]
14. [Diuretics in the treatment of circulatory insufficiency].
Sidorenko BA
Kardiologiia; 1976 Aug; 16(8):140-50. PubMed ID: 1011498
[No Abstract] [Full Text] [Related]
15. The silent revolution.
Hjortdahl P
Scand J Prim Health Care; 1990 Dec; 8(4):188-90. PubMed ID: 2284516
[No Abstract] [Full Text] [Related]
16. Should rheumatologists prescribe statins?
Soubrier M; Bruckert E
Joint Bone Spine; 2010 Mar; 77(2):93-5. PubMed ID: 20207572
[No Abstract] [Full Text] [Related]
17. Should practices start offering pseudo-concierge memberships to patients for added benefits?
MGMA Connex; 2016 Sep; 16(7):45-46. PubMed ID: 30379439
[No Abstract] [Full Text] [Related]
18. Commentary on "no to greed".
Hunt DP
South Med J; 2015 Jan; 108(1):65-6. PubMed ID: 25580762
[No Abstract] [Full Text] [Related]
19. Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.
Mortensen MB; Falk E; Schmidt M
Circ Cardiovasc Qual Outcomes; 2017 Jul; 10(7):. PubMed ID: 28698192
[No Abstract] [Full Text] [Related]
20. Doctors no longer need medical secretaries.
Spence D
BMJ; 2013 Jan; 346():f226. PubMed ID: 23315258
[No Abstract] [Full Text] [Related]
[Next] [New Search]
